Back
Apellis Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$24.96
Seasonality Move:
7.92%
7 Day Trial
ALL ACCESS PASS
$
7
Apellis Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 14.2% based on the past 8 years of stock performance.
-
Apellis Pharmaceuticals, Inc. has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Apellis Pharmaceuticals, Inc. Stock Undervalued?The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.97. The Score for APLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 14.2% based on the past 8 years of stock performance.
Apellis Pharmaceuticals, Inc. Stock Rating
Buy
54
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. overpriced?
-
Apellis Pharmaceuticals, Inc. has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Apellis Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
35.57
52-Week Low:
16.10
Prediction Charts
Market Cap:
3.2B
Price in USD:
24.97
Volume:
786.6K
Beta:
0.88
Technical Analysis
SMA50:
23.16
SMA100:
24.23
SMA200:
21.90
52-Wk Change:
-24.23%
Stock Predictions
-
Is Apellis Pharmaceuticals, Inc. stock public?Yes, Apellis Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Apellis Pharmaceuticals, Inc. stock quote today?The Apellis Pharmaceuticals, Inc. stock price is 24.97 USD today.
-
How to buy Apellis Pharmaceuticals, Inc. stock online?You can buy Apellis Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-8 | 23.87 | 23.79 | 24.45 | 23.57 |
| Dec-9 | 23.74 | 23.78 | 24.16 | 23.54 |
| Dec-10 | 23.85 | 24.68 | 24.71 | 23.69 |
| Dec-11 | 24.66 | 24.97 | 25.52 | 24.53 |
| Dec-12 | 24.93 | 25.23 | 25.28 | 24.45 |
| Dec-15 | 25.07 | 24.56 | 25.56 | 24.47 |
| Dec-16 | 24.49 | 25.31 | 25.89 | 24.01 |
| Dec-17 | 25.04 | 25.20 | 25.95 | 25.02 |
| Dec-18 | 25.31 | 24.48 | 25.74 | 24.25 |
| Dec-19 | 24.45 | 24.65 | 25.18 | 24.36 |
| Dec-22 | 24.67 | 25.40 | 26.12 | 24.40 |
| Dec-23 | 25.60 | 24.82 | 25.91 | 24.75 |
| Dec-24 | 24.88 | 25.16 | 25.20 | 24.74 |
| Dec-26 | 25.08 | 24.97 | 25.08 | 24.58 |
Apellis Pharmaceuticals, Inc. Earnings
Apellis Pharmaceuticals, Inc. Earnings Report: Per Share Apellis Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals, Inc. Forecast Revenue Growth
Apellis Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.44 per share.
* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.